Abstract:Background: Coronary heart disease (CHD) is an intricate and multifaceted cardiovascular disorder that contributes significantly to global morbidity and mortality. Early and accurate identification and diagnosis of CHD are paramount to ensuring patients receive optimal therapeutic interventions and satisfactory outcomes. Methods: Data on CHD gene expression were obtained from the Gene Expression Omnibus (GEO) repository and potential hub genes were screened through gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), weighted gene co-expression network analysis (WGCNA), and least absolute shrinkage and selection operator (LASSO) analyses. Functional validation of these hub genes was conducted by interfering with them in human umbilical vein endothelial cells (HUVECs). Cell proliferation and apoptosis were assessed through cell counting kit-8 (CCK-8) and flow cytometry assays, respectively, while enzyme-linked immunosorbent assay (ELISA), quantitative polymerase chain reaction (qPCR), Western blot, and immunofluorescence were used to measure the expression of key indicators. Results: We identified 700 upregulated differentially expressed genes (DEGs) and 638 downregulated DEGs in CHD, and utilized LASSO analyses to screen disease potential biomarkers, such as zinc finger protein 429 (ZNF429). Interference with ZNF429 in HUVECs mitigated the CHD-induced decrease in cell proliferation and increase in apoptosis. Moreover, the expression of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), cluster of differentiation 62E (CD62E), and cluster of differentiation 62P (CD62P) was reduced, leading to decreased cellular inflammation and adhesion. Conclusions: CHD-associated biomarker ZNF429 was identified through bioinformatics analysis to potentially regulate the expression of inflammatory factors IL-6, IL-1β, and TNF-α, along with adhesion molecules ICAM-1, VCAM-1, CD62E, and CD62P. This modulation influence was subsequently found to impact the progression of CHD. These findings offered valuable insights into potential targets for further investigation and therapeutic interventions for CHD management.

CHD@ZJU: a knowledgebase providing network-based research platform on coronary heart disease.

CHDbase: A Comprehensive Knowledgebase for Congenital Heart Disease-related Genes and Clinical Manifestations

Cardio: a Web-Based Knowledge Resource of Genes and Proteins Related to Cardiovascular Disease.

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

CHDGKB: a Knowledgebase for Systematic Understanding of Genetic Variations Associated with Non-Syndromic Congenital Heart Disease

Pgpm_a_314880 823..837

Cadgene: A Comprehensive Database For Coronary Artery Disease Genes

CDRH: Database of Complex Disease-Related Haplotype in Human

An Update on the CHDGKB for the Systematic Understanding of Risk Factors Associated with Non-Syndromic Congenital Heart Disease

A Survey on Coronary Heart Disease Related Signal Pathways, Drug Targets and Pharmacological Interventions

Identification of Dysfunctional Modules and Disease Genes in Congenital Heart Disease by a Network-Based Approach

T2D@ZJU: a Knowledgebase Integrating Heterogeneous Connections Associated with Type 2 Diabetes Mellitus

In Silico Identification of Common and Specific Signatures in Coronary Heart Diseases

Identification Of Key Genes And Crucial Modules Associated With Coronary Artery Disease By Bioinformatics Analysis

PlateletBase: A Comprehensive Knowledgebase for Platelet Research and Disease Insights

ZNF429 Participates in the Progression of Coronary Heart Disease through Regulating Inflammatory and Adhesive Factors

CBGDA: a manually curated resource for gene-disease associations based on genome-wide CRISPR

CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology

HFBD: a biomarker knowledge database for heart failure heterogeneity and personalized applications

Screening of Candidate Key Genes Associated with Congenital Heart Disease Using Bioinformatics Data Analysis

Prioritizing Congenital Heart Disease Genes From Transcriptome And Interactome Via Pagerank